UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Gut, ISSN 0017-5749, 01/2012, Volume 61, Issue 1, pp. 6 - 32
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Biological and medical sciences | Medical sciences | Prognosis | Pancreatic Neoplasms - diagnosis | Pancreatic Neoplasms - etiology | Humans | Liver Neoplasms - therapy | Lung Neoplasms - therapy | Neuroendocrine Tumors - diagnosis | Gastrointestinal Neoplasms - diagnosis | Gastrointestinal Neoplasms - therapy | Appendiceal Neoplasms - diagnosis | Appendiceal Neoplasms - etiology | Gastrointestinal Neoplasms - etiology | Liver Neoplasms - etiology | Liver Neoplasms - diagnosis | Lung Neoplasms - etiology | Quality of Life | Neuroendocrine Tumors - therapy | Appendiceal Neoplasms - therapy | Neuroendocrine Tumors - etiology | Lung Neoplasms - diagnosis | Pancreatic Neoplasms - therapy | Medical case management | Practice guidelines (Medicine) | Methods | Pathology | Chemotherapy | Algorithms | Medical imaging | Surgery | Metastasis | Family medical history | Cancer therapies | Tumors | Cancer | Index Medicus | Abridged Index Medicus | intestinal obstruction | neuroendocrine cells | gallbladder cancer | pancreatic pathology | decision analysis | histopathology | infective colitis | diarrhoea | Clinical decision-making | Guidelines | peptide receptors | pancreatic cancer | bilary duct carcinoma | salmonella | endocrine tumours | neuroendocrine tumours | cancer | pancreatitis | 1506 | sepsis | pancreatic endocrine tumour | pancreatic tumours
Journal Article
2.
Full Text
Systemic sclerosis associated pulmonary hypertension: improved survival in the current era
Heart (British Cardiac Society), ISSN 1355-6037, 07/2006, Volume 92, Issue 7, pp. 926 - 932
Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiology. Vascular system | Biological and medical sciences | Pulmonary hypertension. Acute cor pulmonale. Pulmonary embolism. Pulmonary vascular diseases | Medical sciences | Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis | Pneumology | Hypertension, Pulmonary - mortality | Prostaglandins - therapeutic use | Prognosis | Vasodilator Agents - therapeutic use | Humans | Middle Aged | Hypertension, Pulmonary - physiopathology | Male | Antihypertensive Agents - therapeutic use | Epoprostenol - therapeutic use | Epoprostenol - analogs & derivatives | Exercise Test | Scleroderma, Systemic - mortality | Sulfonamides - therapeutic use | Scleroderma, Systemic - complications | Scleroderma, Systemic - physiopathology | Survival Analysis | Female | Hemodynamics | Hypertension, Pulmonary - complications | Care and treatment | Research | Systemic scleroderma | Patient outcomes | Pulmonary hypertension | Scleroderma (Disease) | Heart failure | Pulmonary arteries | Funding | Medical prognosis | Diuretics | Drug dosages | Binding sites | Placebo effect | Index Medicus | Abridged Index Medicus | endothelin antagonist | systemic sclerosis | prostanoids | pulmonary arterial hypertension | survival | Cardiovascular Medicine
Journal Article
Cell (Cambridge), ISSN 0092-8674, 11/2016, Volume 167, Issue 5, pp. 1354 - 1368.e14
β-glucan | epigenome | macrophages | human monocytes | trained innate immunity | transcriptome | BLUEPRINT | histone modifications | lipopolysaccharide | endotoxin tolerance | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Sepsis - immunology | Epigenomics | Monocytes - cytology | Humans | Immune Tolerance | Monocytes - immunology | Macrophages - cytology | Gene Regulatory Networks | Immunity, Innate | Lipopolysaccharides - immunology | Sepsis - genetics | DNA Methylation | Histone Code | Immunologic Memory | Transcription, Genetic | Cell Differentiation | beta-Glucans - immunology | Macrophages - immunology | Index Medicus
Journal Article
Annals of the rheumatic diseases, ISSN 0003-4967, 11/2003, Volume 62, Issue 11, pp. 1088 - 1093
Life Sciences & Biomedicine | Rheumatology | Science & Technology | Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis | Biological and medical sciences | Medical sciences | Hypertension, Pulmonary - mortality | Hypertension, Pulmonary - diagnosis | Iloprost | Echocardiography | Humans | Middle Aged | Pulmonary Wedge Pressure | Male | Ventricular Dysfunction, Right - diagnosis | Vasodilator Agents | Cardiac Catheterization | Ventricular Dysfunction, Right - mortality | Epidemiologic Methods | Scleroderma, Systemic - complications | Ventricular Dysfunction, Right - complications | Female | Registries | Aged | Hypertension, Pulmonary - complications | Hypertension | Medical research | Care and treatment | Prognosis | Cookery for hypertensives | Complications | Mortality | Rheumatic diseases | United Kingdom | Research | Patients | Pulmonary artery | Sclerosis | Malta | Prevention | Analysis | Causes of | Physiological aspects | Medicine, Experimental | Health aspects | Studies | Pulmonary fibrosis | Pulmonary arteries | Medical prognosis | Population | Veins & arteries | Index Medicus | Extended Report
Journal Article
European Journal of Political Economy, ISSN 0176-2680, 2006, Volume 22, Issue 4, pp. 1016 - 1019
Journal Article
Current medicinal chemistry, ISSN 0929-8673, 08/2012, Volume 19, Issue 23, pp. 3907 - 3921
Rucaparib | CEP-9722 | GPI-21016 | LT-673 | Olaparib | BRCA1 | Synthetic lethality | BRCA2 | DNA repair | MK-4827 | Poly(ADP-ribose) polymerase (PARP) inhibitors | Veliparib | INO-1001 | Base excision repair (BER) | Iniparib | Triple negative breast cancer | Pharmacology & Pharmacy | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Chemistry, Medicinal | Science & Technology | Neoplasms - metabolism | Humans | Drug Resistance, Neoplasm | Clinical Trials as Topic | Enzyme Inhibitors - therapeutic use | Poly(ADP-ribose) Polymerase Inhibitors | Neoplasms - drug therapy | BRCA1 Protein - genetics | Poly(ADP-ribose) Polymerases - metabolism | BRCA2 Protein - metabolism | BRCA1 Protein - metabolism | DNA Repair | BRCA2 Protein - genetics
Journal Article
Drug design, development and therapy, ISSN 1177-8881, 2018, Volume 12, pp. 2553 - 2565
MEK | NRAS | Advanced | Binimetinib | Melanoma | BRAF | Metastatic | MAPK | ERK | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Chemistry, Medicinal | Science & Technology | Skin Neoplasms - pathology | Skin Neoplasms - drug therapy | Membrane Proteins - genetics | Humans | Mitogen-Activated Protein Kinase Kinases - antagonists & inhibitors | Melanoma - enzymology | Treatment Outcome | Antineoplastic Agents - therapeutic use | Melanoma - pathology | Protein Kinase Inhibitors - adverse effects | Molecular Targeted Therapy | Mitogen-Activated Protein Kinase Kinases - metabolism | Animals | Skin Neoplasms - enzymology | Signal Transduction - drug effects | Antineoplastic Agents - adverse effects | GTP Phosphohydrolases - genetics | Melanoma - genetics | Protein Kinase Inhibitors - therapeutic use | Melanoma - drug therapy | Skin Neoplasms - genetics | Mutation | Antimitotic agents | Care and treatment | Metastasis | Drug therapy | T cells | Antineoplastic agents | Mitogens | Protein kinases | Cancer | PD-1 protein | Lung cancer | Interleukin | Colorectal cancer | Cytotoxicity | Lymphocytes T | Thyroid gland | Males | Kinases | Metastases | Skin cancer | Proteins | CTLA-4 protein | Interleukin 2 | Tumorigenesis | MEK inhibitors | MAP kinase | Genetic diversity | Hypotheses | Inhibitors | Immune checkpoint | Protein kinase | Females | Apoptosis | Tumors | Index Medicus | metastatic | advanced | melanoma | binimetinib
Journal Article